Purpose

The purpose of this study is to compare opioid prescribing practices by either routine provider prescribing practices, or with the use of a calculator, i.e., the Opioid Calculator, published by the University of Michigan (www.opioidcalculator.org), with the intent of decreasing the number of pills.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 80 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women aged 18 to 80 - Undergoing planned laparoscopic hysterectomy as a day surgery procedure

Exclusion Criteria

  • Women aged 18 to 80 - Undergoing a non-laparoscopic unplanned surgical procedure - Patients with a history of opioid use disorder or current opioid use disorder

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
5 Doses
Participants will receive 5 doses of prescription opioids following surgery.
  • Other: 5x Oxycodone Oral Tablets
    Participants will be prescribed 5 doses of 5mg tablets of oxycodone for postoperative pain relief.
Active Comparator
16 Doses
Participants will receive 16 doses of prescription opioids following surgery.
  • Other: 16x Oxycodone Oral Tablets
    Participants will be prescribed 16 doses of 5mg tablets of oxycodone for postoperative pain relief.

Recruiting Locations

University of Tennessee Health Science Center
Memphis, Tennessee 38103
Contact:
Amira Wohabrebbi, PhD
901-545-7453
awohabre@uthsc.edu

More Details

Status
Recruiting
Sponsor
University of Tennessee

Study Contact

Detailed Description

The intent of this study is to validate the use of the Opioid Calculator, published at University of Michigan (www.opioidcalculator.org), which takes several variables into account, including age, risk factors (history of depression, alcohol abuse, others) to determine in a more scientific way the number of pills sufficient to prescribe. The sample size was determined by the number of routine post-op laparoscopic patients seen in our practice. The estimated necessary sample size is 6 participants per group (12 total). Patients will be randomized using 3 block groups of size 4 each. Patients will be approached at in clinic at the time they are consenting to laparoscopic hysterectomy and will be counseled about postoperative pain medication management. Randomization to either standard practice or calculator will be performed using computer-generated, permuted blocks of 4 participants. Sealed randomization envelopes will be opened for each subject on the day of surgery, after anesthesia is initiated. The study will be singled-blinded to the participant. Patients will be contacted on day 2 and day 7 to inquire where they are on the Visual Analog Scale (VAS) and how many pills they have taken. Two weeks after surgery patients will be seen in office for VAS and requested to bring unused pills for accounting purposes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.